AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
7min chapter
328: Pfizer's activist troubles, gene therapy questions, RFK Jr.'s MAHA ambitions
The Readout Loud
Challenges in Duchenne Gene Therapy
This chapter explores the difficulties Pfizer faces with its Duchenne gene therapy program, spotlighting a failed clinical trial that raises questions about the use of microdystrophin as an approval biomarker. It also examines the broader implications for gene therapy evaluations, regulatory standards, and the uncertainty felt by families and physicians regarding effective treatments.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode